Dr Sally Hopewell’s key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews. She has published a number of research studies in these areas including the development of key reporting guidelines such as the CONSORT Statement and PRISMA for Abstracts.
She joined the Oxford Clinical Trials Unit (OCTRU), at the University of Oxford, in February 2015, to take up a new position as Senior Research Fellow in Clinical Trials where she is involved in the design and delivery of a number of trials within the OCTRU portfolio.
Previously, she worked at the Centre for Statistics in Medicine (2007 – 2015) on a MRC funded programme of research related to CONSORT and the conduct and reporting of clinical trials. She also worked, and continues to collaborate with, the Centre d’Epidemiologie Clinique (2012 – present), University Paris Descartes, on research activities related to the methodology of systematic reviews and randomized trials. She is currently running a trial targeting medical journals and evaluating the impact of a web-based tool to improve trial reporting.
Prior to this she worked at the UK Cochrane Centre (2004 – 2012) and with the NHS National Blood Service (2010 – 2012) systematic review programme. In 2005, she was awarded a D.Phil at the University of Oxford, in 2005, on research into the effects of unpublished data in systematic reviews.
Sally has a particular interest in clinical trial registration, data sharing, reporting of clinical trial protocols, pilot trials and trials of non-pharmacological and complex interventions. She is an academic editor for PLoS ONE, sit on the editorial board for the journal Systematic Reviews and is also a member of the advisory board for Current Controlled Trials and the IDEAL Collaboration steering group.